{
  "relevance_rule": {
    "rule_text": "All abstracts that have client provided keywords",
    "approach": "keywords",
    "key_concepts": {
      "keywords": [
        "Hyperphosphatemia",
        "Parathyroid hormone",
        "Calcitriol",
        "Chronic kidney disease",
        "ESRD",
        "Phosphate binder",
        "Sevelamer",
        "sucroferric oxyhydroxide",
        "lanthanum carbonate",
        "Ferric citrate",
        "Calcium acetate",
        "Constipation",
        "Tenapanor",
        "Claudins",
        "FGF receptor",
        "Albuminuria",
        "nicotinamide",
        "vitamin D",
        "SGLT2 inhibitors",
        "canagliflozin",
        "Dapagliflozin",
        "Empagliflozin",
        "Ozempic",
        "Calcium carbonate",
        "Serum phosphate",
        "Phosphate",
        "Fibroblast growth factor 23",
        "Hemodialysis",
        "Dialysis",
        "Dialysis Outcomes and Practice Patterns Study",
        "Sodium hydrogen transport exchanger 3",
        "sodium-dependent phosphate cotransporter 2b",
        "KDIGO",
        "KDOQI",
        "Sodium",
        "Phosphorus",
        "Klotho",
        "Tight junctions",
        "Occludins",
        "Vascular calcification",
        "Bristol Stool Form Scale",
        "Interdialytic weight gain",
        "peritoneal dialysis",
        "NTX1942",
        "SLC34A2",
        "Glomerular",
        "CKD-MBD",
        "Smooth muscle calcification",
        "Oxylanthanum carbonate"
      ],
      "categories": [],
      "contextual_concepts": []
    },
    "reasoning": "Explicitly stated as the relevance rule and matches client provided keywords."
  },
  "priority_rules": [
    {
      "priority": "High",
      "rule_text": "Phase 2 data, Phase 3 data (including meta-analyses), real-world data (including PROs and registry data), Phosphate binders/phosphate lowering treatment",
      "approach": "hybrid",
      "key_concepts": {
        "keywords": [
          "Phase 2",
          "Phase 3",
          "meta-analysis",
          "real-world data",
          "PRO",
          "registry data",
          "Phosphate binder",
          "phosphate lowering treatment"
        ],
        "categories": [
          "Clinical trial phase",
          "Treatment type"
        ],
        "contextual_concepts": [
          "patient reported outcomes",
          "registry studies",
          "meta-analyses"
        ]
      },
      "exclusions": [
        "Phase 1",
        "preclinical",
        "retrospective",
        "prognostic",
        "trial design",
        "general studies",
        "Ardelyx sponsored"
      ],
      "reasoning": "Requires both keyword and context matching for phases, real-world data, and treatment types."
    },
    {
      "priority": "Internal",
      "rule_text": "Ardelyx sponsored abstracts (excluding those that meet High priority criteria)",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "Ardelyx"
        ],
        "categories": [
          "Sponsor"
        ],
        "contextual_concepts": []
      },
      "exclusions": [
        "Phase 2",
        "Phase 3",
        "meta-analysis",
        "real-world data",
        "PRO",
        "registry data",
        "Phosphate binder",
        "phosphate lowering treatment"
      ],
      "reasoning": "Can be identified by sponsor keyword, but must exclude those qualifying for High priority."
    },
    {
      "priority": "Medium",
      "rule_text": "Phase 1 data, retrospective analyses, prognostic studies, trial designs, preclinical studies; studies with trial outcomes and endpoints; other general studies (excluding those that meet High or Internal priority criteria)",
      "approach": "hybrid",
      "key_concepts": {
        "keywords": [
          "Phase 1",
          "retrospective",
          "prognostic",
          "trial design",
          "preclinical",
          "outcomes",
          "endpoints",
          "general study"
        ],
        "categories": [
          "Study type",
          "Trial phase"
        ],
        "contextual_concepts": [
          "trial outcomes",
          "endpoints",
          "general studies"
        ]
      },
      "exclusions": [
        "Phase 2",
        "Phase 3",
        "meta-analysis",
        "real-world data",
        "PRO",
        "registry data",
        "Phosphate binder",
        "phosphate lowering treatment",
        "Ardelyx"
      ],
      "reasoning": "Covers studies not qualifying for High or Internal, needs both keyword and context matching."
    },
    {
      "priority": "Low",
      "rule_text": "All abstracts that only have mention of an indication and does not include any other data (excluding those that meet High, Internal, or Medium priority criteria)",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "indication"
        ],
        "categories": [
          "Indication"
        ],
        "contextual_concepts": []
      },
      "exclusions": [
        "Phase 2",
        "Phase 3",
        "meta-analysis",
        "real-world data",
        "PRO",
        "registry data",
        "Phosphate binder",
        "phosphate lowering treatment",
        "Ardelyx",
        "Phase 1",
        "retrospective",
        "prognostic",
        "trial design",
        "preclinical",
        "outcomes",
        "endpoints",
        "general study"
      ],
      "reasoning": "Only abstracts mentioning indication without any other data, after excluding higher priorities."
    }
  ]
}